# Evaluation of the Plasmatic NGAL as a Predictive Marker of Renal Injury in Children With Urinary Infection. (Perf-NGAL-IU)

> **NCT04191785** · NA · COMPLETED · sponsor: **Fondation Lenval** · enrollment: 50 (actual)

## Conditions studied

- Urinary Tract Infections

## Interventions

- **DIAGNOSTIC_TEST:** plasmatic NGAl and MRI

## Key facts

- **NCT ID:** NCT04191785
- **Lead sponsor:** Fondation Lenval
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-11
- **Primary completion:** 2023-04-20
- **Final completion:** 2023-10-26
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04191785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04191785, "Evaluation of the Plasmatic NGAL as a Predictive Marker of Renal Injury in Children With Urinary Infection. (Perf-NGAL-IU)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04191785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*